Rocket Lab Shares Slide 15% as Neutron Rocket Launch Delayed Until 2027

Rocket Lab (NASDAQ:RKLB) shares came under heavy selling pressure on Wednesday, 14 October, falling 7.85% during regular trading before declining a further 7.4% in after-hours dealings following confirmation that the company’s Neutron rocket would not make its inaugural flight until 2027.

The stock closed the regular session at $59.18, with the subsequent after-hours decline pointing to additional weakness when US markets reopened on Thursday.

The sell-off reflected a combination of broader pressure on growth stocks and company-specific concerns surrounding the development timetable for Neutron, Rocket Lab’s reusable medium-lift launch vehicle.

The company had previously targeted the fourth quarter of 2026 for Neutron’s first flight, making the revised schedule a further setback for a programme central to its expansion into larger satellite launches.

Rocket Lab Falls 7.85% During Regular Trading

Rocket Lab shares were already declining before the company announced the revised Neutron launch schedule.

The stock opened lower on Wednesday in a session characterised by widespread selling across growth and technology stocks.

Stronger-than-expected US inflation data contributed to concerns that the Federal Reserve could maintain higher interest rates for longer or introduce further increases in borrowing costs.

The resulting pressure was particularly pronounced among growth-oriented companies, whose valuations can be sensitive to changes in interest rate expectations.

The Nasdaq Composite declined 1.88% during the session, reflecting broader weakness across technology-related equities.

Rocket Lab’s 7.85% decline during regular trading was not attributed to a specific company announcement at the time, although the shares had already experienced several sessions of weakness.

Insider Share Sale and SpaceX Competition Add to Investor Concerns

Rocket Lab had faced additional selling pressure in the days preceding Wednesday’s decline.

Chief Financial Officer Adam Spice sold approximately $9.9 million worth of company shares on 1 October under a previously established trading plan.

Although the transaction was conducted through a prearranged arrangement, the sale formed part of the recent developments being monitored by investors.

Rocket Lab shares also declined approximately 4% on Monday amid concerns about competition from SpaceX and uncertainty surrounding the timetable for the Neutron programme.

Neutron is intended to provide Rocket Lab with a larger launch vehicle capable of competing in a market currently served by rockets including SpaceX’s Falcon 9.

The programme represents an important element of Rocket Lab’s strategy to expand beyond its existing launch capabilities and compete for larger commercial and government satellite missions.

As a result, uncertainty surrounding the rocket’s development schedule has implications for the company’s future growth plans.

Neutron Maiden Flight Postponed Following Manufacturing Defect

After Wednesday’s closing bell, Rocket Lab confirmed that Neutron’s first flight had been delayed until 2027, replacing its previous target of the fourth quarter of 2026.

The company attributed the postponement to a manufacturing defect affecting the forward dome of the rocket’s first-stage tank.

The affected component is manufactured using composite materials, which are integral to the rocket’s structural design.

Rocket Lab stated that it had identified the corrective measures required to address the defect.

However, the additional work means the company will not meet its previous launch timetable.

Chief Executive Peter Beck defended the decision to postpone the flight, emphasising the importance of reliability and indicating that merely having a possibility of mission success was not an acceptable standard.

The decision reflects the technical challenges involved in developing a new reusable launch vehicle, particularly when manufacturing defects affect critical structural components.

Neutron Programme Faces Another Schedule Revision

The latest postponement adds to a series of delays affecting Neutron since the programme was introduced in 2021.

Rocket Lab initially targeted 2024 for the rocket’s maiden flight before subsequently moving the planned launch date to the fourth quarter of 2026.

The revised 2027 timetable represents another extension of the development period.

Neutron is designed as a reusable medium-lift launch vehicle, intended to allow Rocket Lab to compete for missions requiring greater payload capacity than its existing smaller rocket offerings.

The programme is particularly important to the company’s ambitions to compete more directly with SpaceX, whose Falcon 9 has established a substantial position in the commercial launch market.

Further delays could affect Rocket Lab’s ability to enter this segment on its previously anticipated schedule.

Investors Assess Impact on Rocket Lab’s Growth Strategy

The announcement introduces additional uncertainty over the timing of Rocket Lab’s expansion into medium-lift launch services.

Although the company has identified corrective actions for the manufacturing defect, the revised schedule means investors will need to reassess when Neutron could begin contributing to commercial operations.

The delay also highlights the risks associated with developing complex aerospace systems, where manufacturing issues and testing requirements can materially affect project timelines.

Wednesday’s share price movements reflected both wider market concerns about inflation and interest rates and the specific impact of the Neutron announcement.

Rocket Lab’s ability to resolve the manufacturing issue and progress towards a successful maiden flight in 2027 will remain an important consideration for investors evaluating the company’s longer-term launch ambitions.

Rocket Lab stock price